Trademark Overview
On Sunday, February 4, 2024, a trademark application was filed for INFIRST+ with the United States Patent and Trademark Office. The USPTO has given the INFIRST+ trademark a serial number of 98390551. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Wednesday, September 25, 2024. This trademark is owned by Infirst Healthcare Inc.. The INFIRST+ trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:
Pharmaceutical preparations for the treatment and prevention of cancer, cardiovascular, endocrine or hormonal, gastrointestinal, inflammatory, musculoskeletal, microbial, neurodegenerative, neurological, pain, respiratory, skin, urological conditions, diseases and disorders; Pharmaceutical preparations for inflammatory relief; pain relief medications; headache and migraine treatment preparations; Pharmaceutical preparations for fever relief and the treatment of cough and cold; Pharmaceutical preparations for the treatment of heartburn, upset stomach, gastroesophageal reflux, acid reflux, acid indigestion relief, abdominal and stomach bloating, pain, and excessive gas build-up relief; diarrhea relief medications; Pharmaceutical preparations for the treatment of anti-microbial, anti-viral, and anti-bacterial infections; burn relief medications; acne treatment medications for acne relief, allergy relief medications
Insulin pumps; Medical devices for use in treating or diagnosing abnormal blood sugar levels and diabetes; Medical devices for use in treating or diagnosing abnormal blood sugar levels and diabetes with integrated recorded operating system software, sold as a unit; Microneedle dermal pens
